Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $1.02
61% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6M | $14.0M | $22.2M | $29.2M | $41.4M | $65.2M | $103.2M | $127.2M |
| Cost of revenue | $4.4M | $4.5M | $1.7M | $21.3M | $25.2M | $4.4M | $5.5M | $5.2M |
| Gross profit | $2.1M | $9.5M | $20.5M | $27.6M | $39.2M | $60.8M | $97.7M | $122.0M |
| Gross margin | 32.3% | 67.7% | 92.3% | 94.7% | 94.7% | 93.2% | 94.7% | 95.9% |
| R&D | $3.8M | $3.2M | $2.4M | $3.6M | $5.7M | $7.4M | $10.9M | $8.5M |
| Operating income | −$7.1M | −$4.6M | −$4.1M | −$3.1M | −$257.0K | −$6.2M | $1.2M | $4.5M |
| EBITDA | −$6.9M | −$4.3M | −$3.3M | −$3.4M | $658.2K | −$2.7M | $4.0M | $10.5M |
| Net income | −$6.0M | −$3.2M | −$4.2M | −$4.6M | −$1.2M | −$4.9M | $5.3M | $13.2M |
| Net margin | -91.2% | -22.7% | -18.9% | -15.8% | -2.9% | -7.5% | 5.1% | 10.4% |
| EPS (diluted) | -0.01 | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 | 0.01 | 0.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $153M | $0.01 | $0.01–$0.01 | 1 |
| 2027 | $189M | $0.03 | $0.03–$0.04 | 1 |
| 2028 | $232M | $0.05 | $0.05–$0.06 | 1 |
Forward consensus · source: Financial Modeling Prep
POLYNOVO LTD OTD
No one on the platform currently holds CALZF.
No tracked institution reports a position in CALZF as of their last filing.
No one on the platform has traded CALZF yet.
| +0.00% |
| $334M |
| — |
| FDMDF4DMedical Limited | $3.00 | +0.00% | $1.8B | — |
| JNDOFJINS HOLDINGS Inc. | $47.22 | +0.00% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 3.0× sales vs its 10.3× historical median P/S.
Fair value ≈ $2.11 · price $0.62 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.